Related Experiment Video
Updated: Jul 19, 2026
Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
Published on: April 14, 2010
Targeting of gene expression by siRNA in CML primary cells
Michaela Merkerova1, Hana Klamova, Radim Brdicka
1Institute of Hematology and Blood Transfusion, U nemocnice 1, 128 20, Prague 2, Czech Republic.
Abstract:
Development of array methods contributes to elucidation of many genes expressed during oncogenesis. Our array-based analyses of gene expression in patients with chronic myeloid leukemia (CML) revealed several genes (MMP8, MMP9, PCNA, JNK2, MAPK p38) with significant increased expression. We suppose that the genes may be implicated in the disease development and a siRNA-suppression can elucidate their functions in leukemogenesis. One of the crucial requirements for this purpose is a high efficiency of siRNA delivery into CML primary cells. Using fluorescein-labeled siRNAs we systematically tested a variety of physical and chemical non-vector based transfection methods in order to evaluate which of them gave the most suitable transfer. Chemically synthesized siRNAs against mentioned genes were transfected into the cells and level of knockdown was determined by real time RT-PCR. Chemical transfection reagents (Oligofectamine, Metafectene, siPORT Amine) commonly used to transfect siRNAs in CML cell lines showed very low siRNA delivery in CML primary cells-mRNA levels decreased at the most to 76%. Electroporation achieved better results (suppression to 63%) but it was associated with high degree of cell death (more than 60%). In the study we obtained the best transfection efficiency using nucleofector technology. Gene expressions ranged 22-37% that remained from original levels. According to our results, nucleofection appears to be the only suitable non-viral method for siRNA delivery into the hard-to-transfect CML primary cells.
Insights
Efficiently delivering small interfering RNA (siRNA) into chronic myeloid leukemia (CML) primary cells is crucial for gene function studies. Nucleofection technology proved most effective for siRNA delivery into these challenging cells.
Area of Science:
- Oncology
- Molecular Biology
- Gene Expression Analysis
Background:
- Array-based gene expression analysis aids in understanding oncogenesis.
- Several genes (MMP8, MMP9, PCNA, JNK2, MAPK p38) showed increased expression in chronic myeloid leukemia (CML) patients.
- siRNA suppression is a potential method to elucidate the function of these genes in leukemogenesis.
Purpose of the Study:
- To evaluate non-vector based transfection methods for efficient siRNA delivery into CML primary cells.
- To identify the most suitable method for achieving high siRNA transfection efficiency in CML primary cells.
- To assess the impact of different transfection methods on cell viability.
Main Methods:
- Systematic testing of various physical and chemical non-vector based transfection methods using fluorescein-labeled siRNAs.
- Quantification of gene knockdown levels using real-time RT-PCR after siRNA transfection.
- Evaluation of cell death rates associated with different transfection techniques.
Main Results:
- Chemical transfection reagents resulted in low siRNA delivery (max 76% mRNA reduction) and were inefficient in primary CML cells.
- Electroporation showed improved suppression (63% mRNA reduction) but caused significant cell death (>60%).
- Nucleofector technology achieved the highest transfection efficiency, with gene expression reduced to 22-37% of original levels, and demonstrated minimal impact on cell viability.
Conclusions:
- Nucleofection is the most effective non-viral method for siRNA delivery into primary CML cells.
- This method facilitates the functional study of genes implicated in CML development.
- Nucleofection offers a viable solution for overcoming the challenges of transfecting primary CML cells.
